Filter
54
Filtered Results: 54
Text search:
L.
Mofenson
Featured
Recommendations
3
New Publications
4
Language
Document type
No document type
37
Studies & Reports
7
Guidelines
7
Manuals
3
Countries / Regions
Africa
3
Thailand
2
Kenya
2
Zimbabwe
2
Zambia
2
Lesotho
1
Rwanda
1
Cameroon
1
Senegal
1
Malawi
1
Haiti
1
Tanzania
1
Côte d’Ivoire / Ivory Coast
1
Uganda
1
Brazil
1
Ethiopia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
9
Countries
5
Women & Child Health
2
Public Health
1
Toolboxes
HIV
40
TB
5
COVID-19
3
Mental Health
1
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
Accessed: 19.10.2019
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
Accessed: 20.10.2019
Supplement Article
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018 www.jaids.com
Review
published: 12 August 2016 doi: 10.3389/fpubh.2016.00166
Frontiers in Public Health | www.frontiersin.org 1 August 2016 | Volume 4 | Article 166
Journal of Infection and Public Health 12 (2019) 213–223
